Introduction: Hyperprolactinaemia associated with antipsychotic drug use is a commonly encountered clinical problem, yet no decision-making tools exist to guide whether to scan the pituitary gland. Methods: A 10-year data series was reviewed of 246 patients who were evaluated for prolactin excess with a cannulated prolactin study. All patients had a prolactin drawn immediately following the insertion of a forearm cannula (P1) and a second sample drawn after 120 min bed rest (P2). Comparison was made between patients with a confirmed microprolactinoma (galactorhoea and/or oligomenorrohea with resting hyperprolactinaemia and microadenoma on MRI) against those on dopamine antagonists as well as normal controls. The presence of macroprolactin w...
Prolactin (PRL) is a peptide hormone that consists of 198 aminoacids and synthesizes in lactotrophs ...
PURPOSE: Recent work supports the use of T2-weighted MRI intensity as a tool for treatment stratific...
Background: Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprola...
Context: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic ...
CONTEXT: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic ...
Context: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic ...
CONTEXT: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic ...
International audienceObjective: Both antitumor and antisecretory efficacies of dopamine agonists (D...
CONTEXT: The optimal duration of dopamine agonist (DA) therapy in prolactinoma is unknown. There are...
AbstractThis study investigated the differences in clinical and laboratory features as well as treat...
OBJECTIVE: Both antitumor and antisecretory efficacies of dopamine agonists (DA) make them the first...
Objective: To estimate the proportion of patients with persistent normoprolactinaemia following dopa...
BackgroundWithdrawal of dopamine agonist (DA) therapy in the management of microprolactinoma is comm...
Objective: The aim of the study was to evaluate clinical and laboratorial features of 1234 patients ...
BACKGROUND: Whether the withdrawal of treatment in patients with nontumoral hyperprolactinemia, micr...
Prolactin (PRL) is a peptide hormone that consists of 198 aminoacids and synthesizes in lactotrophs ...
PURPOSE: Recent work supports the use of T2-weighted MRI intensity as a tool for treatment stratific...
Background: Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprola...
Context: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic ...
CONTEXT: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic ...
Context: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic ...
CONTEXT: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic ...
International audienceObjective: Both antitumor and antisecretory efficacies of dopamine agonists (D...
CONTEXT: The optimal duration of dopamine agonist (DA) therapy in prolactinoma is unknown. There are...
AbstractThis study investigated the differences in clinical and laboratory features as well as treat...
OBJECTIVE: Both antitumor and antisecretory efficacies of dopamine agonists (DA) make them the first...
Objective: To estimate the proportion of patients with persistent normoprolactinaemia following dopa...
BackgroundWithdrawal of dopamine agonist (DA) therapy in the management of microprolactinoma is comm...
Objective: The aim of the study was to evaluate clinical and laboratorial features of 1234 patients ...
BACKGROUND: Whether the withdrawal of treatment in patients with nontumoral hyperprolactinemia, micr...
Prolactin (PRL) is a peptide hormone that consists of 198 aminoacids and synthesizes in lactotrophs ...
PURPOSE: Recent work supports the use of T2-weighted MRI intensity as a tool for treatment stratific...
Background: Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprola...